JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: FR-180204 (FR180204) is a novel, potent, selective and ATP-competitive inhibitor of ERK (extracellular signal-regulated kinase) with potential anti-inflammatory activity and has the potential to be used as a new therapy for rheumatoid arthritis. It inhibits ERK1 And ERK2 with Kis of 0.31 uM and 0.14 uM, respectively, and displays 30-fold higher selectivity for ERK over p38alpha (IC50 = 10 uM); It exhibits no/little activity against human recombinant MEK1, MKK4, IKKalpha, PKCalpha, Src, Syc and PDGFalpha at concentrations of > 30 uM.
References: Biochem Biophys Res Commun. 2005 Oct 14; 336(1):357-63; Cell Physiol Biochem. 2012; 29(5-6):667-74.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!